Annual Working Capital
-$15.45 M
-$107.86 M-116.71%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual working capital is -$15.45 million, with the most recent change of -$107.86 million (-116.71%) on December 31, 2023.
- During the last 3 years, EIGR annual working capital has fallen by -$136.62 million (-112.75%).
- EIGR annual working capital is now -112.75% below its all-time high of $121.18 million, reached on December 31, 2020.
Performance
EIGR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$15.45 M
-$53.55 M-140.54%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly working capital is -$15.45 million, with the most recent change of -$53.55 million (-140.54%) on December 31, 2023.
- Over the past year, EIGR quarterly working capital has dropped by -$107.86 million (-116.71%).
- EIGR quarterly working capital is now -110.14% below its all-time high of $152.37 million, reached on March 31, 2021.
Performance
EIGR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
EIGR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -116.7% | -116.7% |
| 3 y3 years | -112.8% | -112.8% |
| 5 y5 years | -116.8% | -116.8% |
EIGR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -116.7% | at low | -111.4% | at low |
| 5 y | 5-year | -112.8% | at low | -110.1% | at low |
| alltime | all time | -112.8% | at low | -110.1% | at low |
Eiger BioPharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$15.45 M(-116.7%) | -$15.45 M(-140.5%) |
| Sep 2023 | - | $38.10 M(-29.1%) |
| Jun 2023 | - | $53.77 M(-26.3%) |
| Mar 2023 | - | $72.91 M(-21.1%) |
| Dec 2022 | $92.41 M(+25.8%) | $92.41 M(-20.4%) |
| Sep 2022 | - | $116.17 M(-14.5%) |
| Jun 2022 | - | $135.86 M(+22.7%) |
| Mar 2022 | - | $110.74 M(+50.7%) |
| Dec 2021 | $73.46 M(-39.4%) | $73.46 M(-4.7%) |
| Sep 2021 | - | $77.07 M(-25.1%) |
| Jun 2021 | - | $102.93 M(-32.4%) |
| Mar 2021 | - | $152.37 M(+25.7%) |
| Dec 2020 | $121.18 M(+45.2%) | $121.18 M(+7.0%) |
| Sep 2020 | - | $113.28 M(+39.5%) |
| Jun 2020 | - | $81.19 M(+17.6%) |
| Mar 2020 | - | $69.03 M(-17.3%) |
| Dec 2019 | $83.44 M(-9.1%) | $83.44 M(-14.6%) |
| Sep 2019 | - | $97.67 M(-15.1%) |
| Jun 2019 | - | $115.05 M(+48.3%) |
| Mar 2019 | - | $77.56 M(-15.5%) |
| Dec 2018 | $91.82 M | $91.82 M(+75.7%) |
| Sep 2018 | - | $52.26 M(-21.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $66.14 M(+150.9%) |
| Mar 2018 | - | $26.36 M(-25.2%) |
| Dec 2017 | $35.22 M(-36.2%) | $35.22 M(+28.6%) |
| Sep 2017 | - | $27.39 M(-22.6%) |
| Jun 2017 | - | $35.39 M(-22.1%) |
| Mar 2017 | - | $45.46 M(-17.7%) |
| Dec 2016 | $55.23 M(+75.0%) | $55.23 M(+6.5%) |
| Sep 2016 | - | $51.86 M(+18.5%) |
| Jun 2016 | - | $43.77 M(-18.3%) |
| Mar 2016 | - | $53.56 M(+69.7%) |
| Dec 2015 | $31.57 M(-61.3%) | $31.57 M(-13.0%) |
| Sep 2015 | - | $36.30 M(-14.3%) |
| Jun 2015 | - | $42.37 M(-35.9%) |
| Mar 2015 | - | $66.13 M(-18.8%) |
| Dec 2014 | $81.48 M(+579.5%) | $81.48 M(-10.6%) |
| Sep 2014 | - | $91.10 M(+89.4%) |
| Jun 2014 | - | $48.09 M(-11.4%) |
| Mar 2014 | - | $54.25 M(+352.5%) |
| Dec 2013 | $11.99 M(-61.5%) | $11.99 M(-40.5%) |
| Sep 2013 | - | $20.14 M(-22.1%) |
| Jun 2013 | - | $25.86 M |
| Dec 2012 | $31.16 M(-310.0%) | - |
| Dec 2011 | -$14.84 M | - |
FAQ
- What is Eiger BioPharmaceuticals annual working capital?
- What is the all time high annual working capital for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual working capital year-on-year change?
- What is Eiger BioPharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly working capital year-on-year change?
What is Eiger BioPharmaceuticals annual working capital?
The current annual working capital of EIGR is -$15.45 M
What is the all time high annual working capital for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual working capital is $121.18 M
What is Eiger BioPharmaceuticals annual working capital year-on-year change?
Over the past year, EIGR annual working capital has changed by -$107.86 M (-116.71%)
What is Eiger BioPharmaceuticals quarterly working capital?
The current quarterly working capital of EIGR is -$15.45 M
What is the all time high quarterly working capital for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly working capital is $152.37 M
What is Eiger BioPharmaceuticals quarterly working capital year-on-year change?
Over the past year, EIGR quarterly working capital has changed by -$107.86 M (-116.71%)